C.-H. Köhne

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein et al. · Annals of Oncology · 2012 · 1.5K citations · Full text

Medicine, Oncology, Surgery +17

RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features

Verena I. Gaidzik, Veronica Teleanu, Elli Papaemmanuil et al. · Leukemia · 2016 · 283 citations

Medicine, Genetics, Molecular Genetics +16

Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)

Gunnar Folprecht, Thomas Gruenberger, Wolf O. Bechstein et al. · Annals of Oncology · 2014 · 262 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer

Tanja Trarbach, Markus Moehler, Volker Heinemann et al. · British Journal of Cancer · 2010 · 180 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015

C.-H. Köhne, Jacques De Grève, J. T. Hartmann et al. · Annals of Oncology · 2007 · 161 citations

Medicine, Oncology, Pharmacology +14